UMIN ID: UMIN000054612
Registered date:08/06/2024
Pharmacokinetics and Prediction of Adverse Effects by EOB-MRI in the Treatment of Pancreatic Cancer with Gemcitabine + Nab-Paclitaxel
Basic Information
| Recruitment status | Pending |
|---|---|
| Health condition(s) or Problem(s) studied | Pancreatic cancer treated with GEM + nab PTX |
| Date of first enrollment | 2024/06/19 |
| Target sample size | 50 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | CIPN events |
|---|---|
| Secondary Outcome | OS,ORR,PFS,AEs |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | 18years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1 Inability to perform contrast-enhanced CT or MRI due to renal dysfunction 2 Inability to undergo MRI examination due to claustrophobia 3 Already receiving treatment for peripheral neuropathy 4 Pregnant 5 Other subjects deemed inappropriate as research subjects by the principal investigator |
Related Information
| Primary Sponsor | Juntendo Univ. |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Japan Society for the Promotion of Science (KAKEN) |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Yusuke Takasaki |
| Address | 2-1-1, Hongo Bunkyo-ku Tokyo Japan 113-8421 |
| Telephone | 03-3813-3111 |
| ytakasa@juntendo.ac.jp | |
| Affiliation | Juntendo Univ. dept of Gastroenterology |
| scientific contact | |
| Name | Hiroyuki Isayama |
| Address | 2-1-1, Hongo Bunkyo-ku Tokyo Japan |
| Telephone | 03-3813-3111 |
| h-isayama@juntendo.ac.jp | |
| Affiliation | Juntendo Univ. dept of Gastroenterology |